Global Protein Expression Systems Market Report 2015: Current Landscape and Future Opportunities

DUBLIN, Oct. 12, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/4xvfkb/protein) has announced the addition of the "Protein Expression Systems Market: Current Landscape and Future Opportunities" report to their offering.

The biologics market is considered to be worth over USD 200 billion and has an increasing number of therapeutically relevant protein based molecules in the pipeline.

The Protein Expression Systems Market: Current Landscape and Future Opportunities report provides an extensive study of the various expression systems commercially available for the purpose of expressing the desired proteins. Selecting an effective and reliable expression system is one of the pre-requisites for pharma companies before they start proof of concept studies for biological molecules. It is well known that a particular expression system is not suitable to express every kind of protein. As such, there are several different types of platforms available to meet the growing demand.

With an extensive pipeline of biologic drugs, protein expression systems are likely to continue to garner significant attention from the biopharmaceutical industry. The report covers various aspects such as key features of these systems, associated products, licensing and services portfolio. We have also covered specific details on CMOs manufacturing biopharmaceutical products highlighting their capabilities, geographical location, scale of operation, type of biologics being manufactured and expression systems being used.

In addition, the report highlights the future growth prospects with respect to manufacturing biological molecules. The report has analyzed the overall biologics pipeline and provided specific details on some important classes such as antibody drug conjugates (ADCs) and bispecific antibodies. In addition, the emerging opportunity presented by the ongoing development of biosimilars has been highlighted. For the purposes of the study, important stakeholders were interviewed to solicit their opinions around the upcoming opportunities and challenges which must be considered for a more inclusive growth. Examples of companies interviewed include Research Corporation Technologies, iBio and Jena Bioscience.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Expression Systems: Key Features and Products

6. Company Profiles

7. CMO Services

8. Opportunity Analysis

9. SWOT Analysis

10. Interview Transcripts

11. Conclusion

12. Appendix 1: Tabulated Data

13. Appendix 2: List of Companies and Organizations

- 3P Biopharmaceuticals

- 5 PRIME

- AAIPharma Services

- AbbVie

- AbGenomics

- Abnova

- AdAlta

- ADC Therapeutics

- Aeras

- Affinicon

- Affinity Life Sciences

- Agilent Technologies

- Ajinomoto Althea

- Aldevron

- Allele Biotechnology

- Alliance Medical Products (Siegfried)

- Alpax Pharmaceuticals

- Ambrx

- AMEGA Biotech

- AMYRA Biotech

- Apotex Fermentation

- Aragen Bioscience

- Artes Biotechnology

- Asahi Glass Co.

- Astellas

- AthenaES

- AutekBio

- Avecia

- Avesta Biotherapeutics and Research

- Avid Bioservices

- Batavia Bioservices

- Bavarian Nordic

- Baxter BioPharma Solutions

- Bayer Healthcare

- BD Biosciences

- Bharat Biotech

- BIBITEC

- Binex Co.

- Bio Elpida

- BioCision

- Bio-Concept

- BioConnection

- BioConvergence

- BioGenomics

- BioGrammatics

- Bioinformatics

- BioIngenium

- BioMARC

- Biomay

- BIOMEVA

- Bioneer

- Frederick National Laboratory for Cancer Research (FNLCR)

- BioPharmaceuticals Australia

- Bio-Rad Laboratories

- BioReliance

- BioSavita

- BioSynergy

- Biotechnique

- Biotechpharma

- Biotest

- BioVectra

- Biovest International

- Biovian

- Biovolutions

- BioXcellence (Boehringer Ingelheim)

- Bristol Myers Squibb

- BroadOak Capital Partners

- Cantab Biopharmaceuticals

- Catalent

- Catalyst biosciences

- Cellca

- Celldex Therapeutics

- CellFree Sciences

- Celgene

- Celonic

- Center for Biocatalysis and Bioprocessing, The University of Iowa

- Cerbios-Pharma

- CEVEC Pharmaceuticals

- ChemPartner

- Cilian

- Clontech (a Takara Bio Company)

- CMC Biologics

- Cobra Biologics

- Cognate BioServices

- Concord Biotech

- Cook Pharmica

- Creative Biolabs

- Crucell

- Cytovance Biologics

- Dalton Pharma Services

- Development Center for Biotechnology, Taiwan

- DisperSol technologies

- DM BIO DONG-A meiji

- Dow Pharma

- Dyadic International

- Emergent BioSolutions

- Enteris BioPharma

- Esperance Pharmaceuticals

- EUCODIS Bioscience

- Eurogentec

- Florida Biologix

- FormATECH

- Formation Biologics

- FUJIFILM Diosynth Biotechnologies

- Fujirebio Europe

- Gala Biotech (Catalent subsidiary)

- GeneCopoeia

- Geneva Biotech

- Genhelix (mAbxience group)

- Genmab

- GlaxoSmithKline Biopharmaceuticals

- Glide Pharma

- Glycotope Group

- Gold Standard Diagnostics

- Goodwin Biotechnology

- Grand River Aseptic Manufacturing

- GREENOVATION

- GTP Technology

- HALIX

- Hisun Pharmaceuticals USA

- Hong Kong Institute of Biotechnology

- Hospira One 2 One

- iBIO

- IDT Biologika

- Inno Biologics

- Innovent Biologics

- Intas Pharmaceuticals

- Integrity Bio

- Intrexon

- Irvine Pharmaceutical Services

- Jena Bioscience

- Jenrin Discovery

- KABS Pharmaceutic Services

- Kairos Therapeutics

- KBI BioPharma

- Kemwell Biopharma

- Kentucky BioProcessing

- Lampire Biological Laboratories

- Leinco Technologies

- LFB Biomanufacturing

- Life Technologies

- LifeSensors

- Lonza

- Lucigen

- Lyophilization Services of New England.

- Mabion

- Maine Biotechnology Services

- MassBiologics

- MBI International

- Medicago

- Memorial Sloan-Kettering Cancer centre

- Menarini Biotech

- Merck KGaA

- Merck Millipore

- Merck Serono

- Meridian Life Science

- Miltenyi Biotec

- MoBiTec

- Mycenax Biotech

- Neuland Laboratories

- New England Biolabs

- Nextar Chempharma Solutions

- Norwegian Institute of Public Health

- Nova Laboratories

- Novasep

- Novozymes

- OctoPlus

- Omnia Biologics

- Orflo Technologies

- OsoBio (AMRI)

- Oxford Expression Technologies

- PacificGMP

- PATH

- Paragon Bioservices

- Patheon (unit of DPx Holdings)

- Pfizer CentreSource

- PharmaSynth

- Pharmedartis

- Phyton Biotech

- Piramal Pharma Solutions

- Plant BioScience

- Plasmid Factory

- Polymun Scientific

- Premas Biotech

- ProBioGen

- ProteoNic

- Progenitor Cell Therapy

- ProMab Biotechnologies

- Promega Corporation

- Protalix Biotherapeutics

- Provantage Biodevelopment Center

- PX'Therapeutics

- PYRAMID Laboratories

- QuaDPharma

- Reliance Life Sciences

- Rentschler Biotechnologie

- Research Corporation Technologies

- Rhein Biotech

- Richter-Helm BioTec

- RiNA

- SAFC

- Samsung BioLogics

- Sandoz

- Sanofi Pasteur

- Sanofi CEPiA

- Sanquin Pharmaceutical Services

- Scarab Genomics

- Scil Proteins

- Shasun

- SICOR Biotech (Teva)

- Sigma-Aldrich Corporation

- Sinocelltech

- Statens Serum Institut

- Strides Arcolab

- Sutro Biopharma

- Symbiosis Pharmaceutical Services

- SynCo Bio Partners

- Syngene (Subsidiary of Biocon)

- Synthon

- Sypharma

- Tetragenetics

- Teva Pharmaceuticals

- Therapure Biopharma

- Thermo Fisher Scientific

- Toyobo Biologics

- Trenzyme

- University of California, San Francisco (UCSF)

- University of Nebraska

- Valneva

- Vetter Pharma International

- VGXI

- Vibalogics

- Vista Biologicals Corp.

- Vivalis SA

- VTU Technology

- Wacker Biotech

- Waisman Biomanufacturing

- Wockhardt

- WuXi AppTec

- Xbrane Bioscience

- Xcelience

- Zhejiang Medicine Co.

- Zymeworks

For more information visit http://www.researchandmarkets.com/research/4xvfkb/protein

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets